RIPA buffer drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (12)
Papers in which this entity is mentioned.
- LINE-1 retrotransposons mediate cis-acting transcriptional control in human pluripotent stem cells and regulate early brain development. (2025)
- FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. (2025)
- Prenatal alcohol exposure disrupts Sonic hedgehog pathway and primary cilia genes in the mouse neural tube. (2021)
- Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. (2019)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
- CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
- Position-specific binding of FUS to nascent RNA regulates mRNA length. (2015)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
- The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
- Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ripa buffer | drug | 37 | 49 |